Novel homozygous p.R454C mutation in the CYP11B1 gene leads to 11beta-hydroxylase deficiency in a Chinese patient.
Article Details
- CitationCopy to clipboard
Wu C, Zhou Q, Wan L, Ni L, Zheng C, Qian Y, Jin J
Novel homozygous p.R454C mutation in the CYP11B1 gene leads to 11beta-hydroxylase deficiency in a Chinese patient.
Fertil Steril. 2011 Mar 1;95(3):1122.e3-6. doi: 10.1016/j.fertnstert.2010.09.035. Epub 2010 Oct 14.
- PubMed ID
- 20947076 [ View in PubMed]
- Abstract
OBJECTIVE: To show mutational analysis for 11beta-hydroxylase deficiency (11beta-OHD). DESIGN: Case report. SETTING: A laboratory of endocrinology at a university hospital. PATIENT(S): One Chinese woman with 11beta-OHD referred to our clinic was observed in our study. INTERVENTION(S): Genomic DNA was extracted from peripheral blood leukocytes, and coding sequence abnormalities of the CYP11B1 gene were assessed by polymerase chain reaction and then direct sequencing analysis. MAIN OUTCOME MEASURE(S): Molecular characterization of the CYP11B1 gene. RESULT(S): A novel missense mutation (p.R454C) in the CYP11B1 gene was identified in our patient. CONCLUSION(S): Our study identified one novel mutation in the CYP11B1 gene. The expanded mutation database should benefit patients in the diagnosis and treatment of 11beta-OHD.